Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, an
- PDF / 2,270,304 Bytes
- 18 Pages / 595.276 x 790.866 pts Page_size
- 59 Downloads / 160 Views
POSITION STATEMENT
Open Access
Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality Kosaku Nitta1, Shunsuke Goto1,2*, Ikuto Masakane1, Norio Hanafusa1, Masatomo Taniguchi1, Takeshi Hasegawa1, Shigeru Nakai1, Atsushi Wada1, Takayuki Hamano1, Junichi Hoshino1, Nobuhiko Joki1, Masanori Abe1, Keiichi Yamamoto1, Hidetomo Nakamoto1 and on behalf of the Japanese Society for Dialysis Therapy Renal Data Registry Committee
Abstract The annual survey of the Japanese Society for Dialysis Therapy Renal Data Registry (JRDR) was sent to 4458 dialysis facilities at the end of 2018; among these facilities, 4402 facilities (98.7%) responded to the facility questionnaire, and 4222 (94.7%) responded to the patient questionnaire. The number of chronic dialysis patients in Japan continues to increase every year; as of the end of 2018, it had reached 339,841 patients, representing 2688 patients per million population. Among the prevalent dialysis patients, the mean age was 68.75 years, and diabetic nephropathy was the most common primary disease among the prevalent dialysis patients (39.0%), followed by chronic glomerulonephritis (26.8%) and nephrosclerosis (10.8%). The number of incident dialysis patients was 40, 468, and a reduction by 491 from 2017. The mean age of the incident dialysis patients was 69.99 years old. Diabetic nephropathy was also the most common primary disease (42.3%), representing a 0.2 percent point reduction from 2017. The distribution of diabetic nephropathy appears to have reached a plateau. The number of deceased patients during 2018 was 33,863, and the crude annual death rate was 10.0%. Heart failure was the most common cause of death (23.5%), followed by infection (21.3%) and malignant tumor (8.4%); these causes were similar to (Continued on next page)
* Correspondence: [email protected] This article is translated from part of a Japanese article that was originally published as “Annual Dialysis Data Report 2018, JSDT Registry” in the Journal of the Japanese Society for Dialysis Therapy, 2019; 52: 679-754 with permission from the Japanese Society for Dialysis Therapy. The original work is at “https://doi.org/10.4009/jsdt.52.679” (Accessed May 19, 2020). The original Japanese report contained 11 chapters with 71 figures, 4 tables and 71 supplementary tables; as this report was too large to submit to Renal Replacement Therapy, we reconstructed it into three English manuscripts. This article is one of three manuscripts. 1 Japanese Society for Dialysis Therapy Renal Data Registry Committee, Japanese Society for Dialysis Therapy, Tokyo, Japan 2 Division of Nephrology and Kidney Center, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan © The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credi
Data Loading...
